Hims & Hers Health (HIMS)
NYSEMarket Open
Hims & Hers Health, Inc. is a consumer-focused telehealth company that connects patients with licensed medical providers through digital platforms branded as Hims and Hers. The company targets common, often stigmatized health and wellness categories by combining online consultations, personalized treatment plans, and direct-to-consumer fulfillment.
Its services cover areas such as sexual health, hair loss, dermatology, mental health, primary care, and weight management. Products may include generic and branded prescription medicines, compounded prescriptions where permitted, over-the-counter treatments, supplements, cosmetics, and related wellness items. The platform is designed to make care feel more accessible and discreet, with asynchronous or virtual provider interactions, electronic medical records, and pharmacy fulfillment integrated into the customer experience.
Hims & Hers operates primarily on a cash-pay model rather than relying on insurance reimbursement. Customers typically pay directly for visits, subscriptions, and products, which gives the company more control over pricing and user experience but also makes affordability and retention important drivers of growth. Its subscription model is a key part of the business, supporting recurring revenue and ongoing engagement for treatments that require continuity.
The company is available across the United States and has expanded into select international markets, including the UK. Its competitive position rests on brand recognition, digital marketing, clinical network management, convenience, and the ability to personalize offerings at scale. As with other healthcare platforms, it operates within a highly regulated environment covering prescribing practices, pharmacy operations, advertising, privacy, and state-by-state medical rules.
Last updated
- Market Cap
- $7,433,365,338
- P/E
- —
- P/FCF
- 111.15
- P/S
- 3.14
- Enterprise Value
- $8,185,205,338
- Sector
- Health Care
- Industry
- Health Care Services
- Address
- 2269 CHESTNUT ST, SAN FRANCISCO, CA, 94123
Hims & Hers Health (HIMS) & Novo Nordisk A/S (NVO): Two Weight-Loss Pill Players Just Got Punished for Growing Fast
Hims & Hers CEO Andrew Dudum pushes back on FTC lawsuit
Hims & Hers CEO pushes back against FTC suit, says "we are active disruptors"
Elite Pharmaceuticals Inc (ELTP) (Q1 2027) Earnings Call Highlights: Steady Revenue and ...
Uniphore Launches Marketing AI to Usher in New Era: NYSE Content Update
Hims & Hers (HIMS) Raised Guidance. Can Growth Survive Its GLP-1 Margin Reset?
Hims & Hers stock trims losses following quarterly results
Wall St set for higher open as investors weigh fresh US-Iran peace deal reports
Stocks making the biggest moves premarket: Riot Platforms, Hims & Hers Health, Intel & more
Wall St futures muted as US-Iran impasse lifts oil prices
Hims & Hers stock drops 7% despite higher guidance: what went wrong?
Why Hims & Hers Is the Perfect Acquisition Target (Even If a Deal Never Happens)
1 Russell 2000 Stock with Exciting Potential and 2 We Ignore
2 Growth Stocks with Explosive Upside and 1 That Underwhelm
Here Comes the Next Wave of GLP-1s. They’ll Treat a Lot More Than Obesity.
Sector Update: Healthcare Stocks Softer Late Afternoon
Update: FTC Suing Hims & Hers for Allegedly Sharing User Data With Meta, Snap
1 Cash-Producing Stock to Target This Week and 2 Facing Headwinds
Principal US Small-Cap ETF Experiences Big Inflow
Hims & Hers stock jumps as Canaccord lifts target price ahead of FDA review
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- $7,433,365,338
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- $8,185,205,338
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- 16.66
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 3.14
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 217.85
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 3.45
- EPS
- -0.06
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 111.15
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 26.52
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- $66,875,000
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- -2.97%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- -0.58%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 2.18
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 1.69
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 1.56
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.36
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- $14,415,456
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 31.86
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 608.1M | 617.82M | 598.98M | 544.83M | 586.01M |
| Cost of revenue | 211.32M | 173.38M | 156.92M | 128.64M | 155.32M |
| Gross profit | 396.79M | 444.44M | 442.06M | 416.2M | 430.69M |
| Operating income | -78.32M | 9.19M | 11.81M | 26.72M | 57.9M |
| EBITDA | -56.37M | 27.28M | 29.48M | 37.19M | 66.17M |
| Net income | -92.12M | 20.6M | 15.77M | 42.51M | 49.49M |
| Income taxes | -9.44M | -2.25M | -3.55M | -9.65M | 11.01M |
| Interest expense | 0 | 0 | 0 | 0 | 0 |
| Other operating expenses | 96.5M | 80.07M | 76.85M | 66.49M | 63.03M |
| Total operating expenses | 475.11M | 435.25M | 430.25M | 389.47M | 372.79M |
| Basic EPS | -0.4 | 0.09 | 0.07 | 0.19 | 0.22 |
| Diluted EPS | -0.4 | 0.07 | 0.06 | 0.17 | 0.2 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 2.27B | 2.15B | 2.23B | 1.88B | 891.71M |
| Total liabilities | 1.82B | 1.61B | 1.65B | 1.31B | 342.45M |
| Total equity | 446.17M | 540.93M | 580.98M | 562.7M | 549.26M |
| Cash & equivalents | 222.27M | 228.62M | 345.78M | 1.12B | 273.74M |
| Current assets | 1.05B | 767.64M | 845.26M | 1.36B | 446.96M |
| Current liabilities | 618.78M | 404.43M | 450.79M | 272.23M | 280.36M |
| Accounts payable | 306.87M | 143.28M | 198.41M | 105.01M | 108.92M |
| Receivables | 149.62M | 32.15M | 0 | 0 | 0 |
| Inventories | 79.07M | 80.13M | 105.99M | 141.8M | 76.1M |
| Goodwill | 342.84M | 278.33M | 259.24M | 117.75M | 117.75M |
| Long-term debt | 974.11M | 972.58M | 971.02M | 969.47M | 0 |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | 89.36M | 61.31M | 148.72M | -19.12M | 109.09M |
| Investing cash flow | -15.45M | -83.68M | -887.4M | -21.09M | -32.8M |
| Financing cash flow | -77.88M | -97.52M | -39.01M | 889.17M | -23.02M |
| Change in cash | -6.35M | -117.16M | -779.17M | 849.99M | 53.52M |
| Net income | -92.12M | 20.6M | 15.77M | 42.51M | 49.49M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 144 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 144 — Hims & Hers Health, Inc. | View Filing | |
| form 4 | Form 4 — Okupe Oluyemi | View Filing | |
| form 4 | Form 4 — Okupe Oluyemi | View Filing | |
| form 4 | Form 4 — Okupe Oluyemi | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| form 4 | Form 4 — Payne Christopher D | View Filing | |
| form 4 | Form 4 — Payne Christopher D | View Filing | |
| form 4 | Form 4 — Payne Christopher D | View Filing | |
| form 4 | Form 4 — Becklund Irene | View Filing | |
| form 4 | Form 4 — Becklund Irene | View Filing | |
| form 4 | Form 4 — Becklund Irene | View Filing | |
| form 4 | Form 4 — Becklund Irene | View Filing | |
| form 4 | Form 4 — Becklund Irene | View Filing | |
| form 4 | Form 4 — Becklund Irene | View Filing | |
| form 4 | Form 4 — Elshenawy Mohamed | View Filing | |
| form 4 | Form 4 — Elshenawy Mohamed | View Filing | |
| form 4 | Form 4 — Elshenawy Mohamed | View Filing | |
| form 4 | Form 4 — Elshenawy Mohamed | View Filing | |
| form 4 | Form 4 — Elshenawy Mohamed | View Filing | |
| form 4 | Form 4 — WELLS DAVID B | View Filing | |
| form 4 | Form 4 — WELLS DAVID B | View Filing | |
| form 4 | Form 4 — Autor Deborah M. | View Filing | |
| form 4 | Form 4 — Autor Deborah M. | View Filing | |
| form 4 | Form 4 — Autor Deborah M. | View Filing | |
| form 4 | Form 4 — Okupe Oluyemi | View Filing | |
| form 4 | Form 4 — Okupe Oluyemi | View Filing | |
| form 4 | Form 4 — Okupe Oluyemi | View Filing | |
| form 4 | Form 4 — Okupe Oluyemi | View Filing | |
| form 4 | Form 4 — Okupe Oluyemi | View Filing | |
| form 4 | Form 4 — Okupe Oluyemi | View Filing | |
| form 4 | Form 4 — Chi Michael | View Filing | |
| form 4 | Form 4 — Chi Michael | View Filing | |
| form 4 | Form 4 — Chi Michael | View Filing | |
| form 4 | Form 4 — Chi Michael | View Filing | |
| form 4 | Form 4 — Chi Michael | View Filing | |
| form 4 | Form 4 — Chi Michael | View Filing | |
| form 4 | Form 4 — Chi Michael | View Filing | |
| form 4 | Form 4 — Dudum Andrew | View Filing | |
| form 4 | Form 4 — Dudum Andrew | View Filing | |
| form 4 | Form 4 — Dudum Andrew | View Filing | |
| form 4 | Form 4 — Dudum Andrew | View Filing | |
| form 4 | Form 4 — Dudum Andrew | View Filing | |
| form 4 | Form 4 — Dudum Andrew | View Filing | |
| form 4 | Form 4 — Dudum Andrew | View Filing | |
| form 4 | Form 4 — Dudum Andrew | View Filing | |
| form 4 | Form 4 — Dudum Andrew | View Filing | |
| form 4 | Form 4 — Dudum Andrew | View Filing | |
| form 4 | Form 4 — Dudum Andrew | View Filing | |
| form 4 | Form 4 — Dudum Andrew | View Filing | |
| form 4 | Form 4 — Dudum Andrew | View Filing | |
| form 4 | Form 4 — Dudum Andrew | View Filing |